A post marketing surveillance study of Prax A 75 (fixed dose combination capsule containing prasugrel 10mg and aspirin 75mg) in patients with Acute Coronary Syndrome (ACS) who are to be managed with Percutaneous Coronary Intervention (PCI).

Trial Profile

A post marketing surveillance study of Prax A 75 (fixed dose combination capsule containing prasugrel 10mg and aspirin 75mg) in patients with Acute Coronary Syndrome (ACS) who are to be managed with Percutaneous Coronary Intervention (PCI).

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Feb 2017

At a glance

  • Drugs Aspirin/prasugrel (Primary)
  • Indications Acute coronary syndromes
  • Focus Adverse reactions
  • Sponsors Torrent Pharmaceuticals
  • Most Recent Events

    • 30 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top